Sponsor Pipeline

Applied Biology, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
8
Active Trials
1
Recruiting
4
Phase 3
Active Trials by Phase
Phase 3
3
Phase 2/3
1
Phase 1/2
2
Early Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06501924 Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss Androgenetic Alopecia Not Yet Recruiting
NCT06745336 Clinical Study of CS-001 As a Treatment for Canities (Grey Hair) Canities Not Yet Recruiting
NCT06762548 Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia Chemotherapy Induced Alopecia Not Yet Recruiting
Phase 2/3
NCT06648850 Clinical Study of DA-001 as a Treatment for Hair Shedding Reduction and Hair Re-Growth Telogen Effluvium Not Yet Recruiting
Phase 1/2
NCT07166354 Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities) Canities Not Yet Recruiting
NCT07397325 Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia Chemotherapy Induced Alopecia Not Yet Recruiting
Early Phase 1
NCT07033845 Pharmacokinetic Study of Topical Phenylephrine Chemotherapy Induced Alopecia Recruiting
NCT07402330 Pharmacokinetic Study of DA-020 Chemotherapy Induced Alopecia Not Yet Recruiting
Get alerts when Applied Biology, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free